MAXLINEAR INC (MXL) Fundamental Analysis & Valuation

NASDAQ:MXL • US57776J1007

Current stock price

17 USD
-0.16 (-0.93%)
At close:
16.67 USD
-0.33 (-1.94%)
After Hours:

This MXL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. MXL Profitability Analysis

1.1 Basic Checks

  • In the past year MXL was profitable.
  • MXL had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: MXL reported negative net income in multiple years.
  • MXL had a positive operating cash flow in 4 of the past 5 years.
MXL Yearly Net Income VS EBIT VS OCF VS FCFMXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • With a Return On Assets value of -17.16%, MXL is not doing good in the industry: 78.26% of the companies in the same industry are doing better.
  • The Return On Equity of MXL (-30.25%) is worse than 80.00% of its industry peers.
Industry RankSector Rank
ROA -17.16%
ROE -30.25%
ROIC N/A
ROA(3y)-17.43%
ROA(5y)-7.54%
ROE(3y)-29.47%
ROE(5y)-12.27%
ROIC(3y)N/A
ROIC(5y)N/A
MXL Yearly ROA, ROE, ROICMXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • MXL has a Gross Margin of 56.84%. This is in the better half of the industry: MXL outperforms 79.13% of its industry peers.
  • MXL's Gross Margin has improved in the last couple of years.
  • MXL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.67%
GM growth 5Y5.03%
MXL Yearly Profit, Operating, Gross MarginsMXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MXL Health Analysis

2.1 Basic Checks

  • MXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MXL has been increased compared to 1 year ago.
  • MXL has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, MXL has a worse debt to assets ratio.
MXL Yearly Shares OutstandingMXL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MXL Yearly Total Debt VS Total AssetsMXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • MXL has an Altman-Z score of 1.94. This is not the best score and indicates that MXL is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.94, MXL is not doing good in the industry: 70.43% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.27 indicates that MXL is not too dependend on debt financing.
  • MXL has a Debt to Equity ratio (0.27) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 1.94
ROIC/WACCN/A
WACC11.61%
MXL Yearly LT Debt VS Equity VS FCFMXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

2.3 Liquidity

  • A Current Ratio of 1.34 indicates that MXL should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.34, MXL is doing worse than 84.35% of the companies in the same industry.
  • MXL has a Quick Ratio of 1.34. This is a bad value and indicates that MXL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of MXL (0.92) is worse than 87.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 0.92
MXL Yearly Current Assets VS Current LiabilitesMXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MXL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 132.97% over the past year.
  • The earnings per share for MXL have been decreasing by -19.18% on average. This is quite bad
  • MXL shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.71%.
  • Measured over the past years, MXL shows a decrease in Revenue. The Revenue has been decreasing by -0.46% on average per year.
EPS 1Y (TTM)132.97%
EPS 3Y-58.61%
EPS 5Y-19.18%
EPS Q2Q%311.11%
Revenue 1Y (TTM)29.71%
Revenue growth 3Y-25.26%
Revenue growth 5Y-0.46%
Sales Q2Q%48.03%

3.2 Future

  • The Earnings Per Share is expected to grow by 57.93% on average over the next years. This is a very strong growth
  • MXL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.47% yearly.
EPS Next Y191.35%
EPS Next 2Y95.94%
EPS Next 3Y57.93%
EPS Next 5YN/A
Revenue Next Year21.32%
Revenue Next 2Y15.89%
Revenue Next 3Y13.47%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MXL Yearly Revenue VS EstimatesMXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
MXL Yearly EPS VS EstimatesMXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. MXL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 56.67 indicates a quite expensive valuation of MXL.
  • MXL's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 24.89, MXL is valued quite expensively.
  • With a Price/Forward Earnings ratio of 19.45, MXL is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MXL indicates a rather cheap valuation: MXL is cheaper than 82.61% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, MXL is valued at the same level.
Industry RankSector Rank
PE 56.67
Fwd PE 19.45
MXL Price Earnings VS Forward Price EarningsMXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MXL Per share dataMXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MXL's earnings are expected to grow with 57.93% in the coming years.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y95.94%
EPS Next 3Y57.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MXL Dividend Analysis

5.1 Amount

  • No dividends for MXL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MXL Fundamentals: All Metrics, Ratios and Statistics

MAXLINEAR INC

NASDAQ:MXL (3/27/2026, 8:00:01 PM)

After market: 16.67 -0.33 (-1.94%)

17

-0.16 (-0.93%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners86.35%
Inst Owner Change3.05%
Ins Owners6.65%
Ins Owner Change0.23%
Market Cap1.47B
Revenue(TTM)467.64M
Net Income(TTM)-136.68M
Analysts72
Price Target21.98 (29.29%)
Short Float %6.7%
Short Ratio4.66
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.79%
Min EPS beat(2)5.09%
Max EPS beat(2)16.48%
EPS beat(4)3
Avg EPS beat(4)7.11%
Min EPS beat(4)-3.14%
Max EPS beat(4)16.48%
EPS beat(8)5
Avg EPS beat(8)3.12%
EPS beat(12)8
Avg EPS beat(12)0.89%
EPS beat(16)11
Avg EPS beat(16)1.77%
Revenue beat(2)2
Avg Revenue beat(2)0.17%
Min Revenue beat(2)0.16%
Max Revenue beat(2)0.19%
Revenue beat(4)3
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)2.67%
Revenue beat(8)6
Avg Revenue beat(8)-0.44%
Revenue beat(12)6
Avg Revenue beat(12)-1.16%
Revenue beat(16)7
Avg Revenue beat(16)-0.99%
PT rev (1m)0%
PT rev (3m)5.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.17%
EPS NY rev (1m)0.82%
EPS NY rev (3m)15.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.62%
Valuation
Industry RankSector Rank
PE 56.67
Fwd PE 19.45
P/S 3.14
P/FCF N/A
P/OCF 74.91
P/B 3.25
P/tB 17.41
EV/EBITDA N/A
EPS(TTM)0.3
EY1.76%
EPS(NY)0.87
Fwd EY5.14%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.23
OCFY1.33%
SpS5.41
BVpS5.23
TBVpS0.98
PEG (NY)0.3
PEG (5Y)N/A
Graham Number5.94
Profitability
Industry RankSector Rank
ROA -17.16%
ROE -30.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.84%
FCFM N/A
ROA(3y)-17.43%
ROA(5y)-7.54%
ROE(3y)-29.47%
ROE(5y)-12.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.67%
GM growth 5Y5.03%
F-Score6
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 45%
Cap/Sales 4.23%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 0.92
Altman-Z 1.94
F-Score6
WACC11.61%
ROIC/WACCN/A
Cap/Depr(3y)44.88%
Cap/Depr(5y)58.82%
Cap/Sales(3y)5.17%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)132.97%
EPS 3Y-58.61%
EPS 5Y-19.18%
EPS Q2Q%311.11%
EPS Next Y191.35%
EPS Next 2Y95.94%
EPS Next 3Y57.93%
EPS Next 5YN/A
Revenue 1Y (TTM)29.71%
Revenue growth 3Y-25.26%
Revenue growth 5Y-0.46%
Sales Q2Q%48.03%
Revenue Next Year21.32%
Revenue Next 2Y15.89%
Revenue Next 3Y13.47%
Revenue Next 5YN/A
EBIT growth 1Y39.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.27%
EBIT Next 3Y68.44%
EBIT Next 5YN/A
FCF growth 1Y99.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.31%
OCF growth 3Y-63.04%
OCF growth 5Y-23.24%

MAXLINEAR INC / MXL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MAXLINEAR INC (MXL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MXL.


What is the valuation status of MAXLINEAR INC (MXL) stock?

ChartMill assigns a valuation rating of 3 / 10 to MAXLINEAR INC (MXL). This can be considered as Overvalued.


Can you provide the profitability details for MAXLINEAR INC?

MAXLINEAR INC (MXL) has a profitability rating of 2 / 10.


What is the valuation of MAXLINEAR INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MAXLINEAR INC (MXL) is 56.67 and the Price/Book (PB) ratio is 3.25.


Can you provide the financial health for MXL stock?

The financial health rating of MAXLINEAR INC (MXL) is 2 / 10.